S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93

STAAR Surgical Stock Forecast, Price & News

+2.14 (+1.75 %)
(As of 10/25/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume156,594 shs
Average Volume527,157 shs
Market Capitalization$5.91 billion
P/E Ratio296.71
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical logo

About STAAR Surgical

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.


See More Headlines

Industry, Sector and Symbol

Ophthalmic goods
Health Care Supplies
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$163.46 million
Cash Flow
$0.36 per share
Book Value
$4.28 per share


Net Income
$5.91 million




Market Cap
$5.91 billion
Next Earnings Date
11/3/2021 (Confirmed)

Social Links


Overall MarketRank

2.09 out of 5 stars

Medical Sector

473rd out of 1,360 stocks

Ophthalmic Goods Industry

2nd out of 5 stocks

Analyst Opinion: 2.1Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

Is STAAR Surgical a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" STAAR Surgical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View analyst ratings for STAAR Surgical
or view top-rated stocks.

What stocks does MarketBeat like better than STAAR Surgical?

Wall Street analysts have given STAAR Surgical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but STAAR Surgical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for STAAR Surgical

How can I listen to STAAR Surgical's earnings call?

STAAR Surgical will be holding an earnings conference call on Wednesday, November 3rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 929-458-6194 with passcode "403818".

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its earnings results on Tuesday, August, 3rd. The medical instruments supplier reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.14. The medical instruments supplier earned $62.37 million during the quarter, compared to the consensus estimate of $52.61 million. STAAR Surgical had a net margin of 10.08% and a trailing twelve-month return on equity of 14.07%. The company's quarterly revenue was up 77.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.03 earnings per share.
View STAAR Surgical's earnings history

How has STAAR Surgical's stock price been impacted by COVID-19?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, STAA stock has increased by 344.9% and is now trading at $124.62.
View which stocks have been most impacted by COVID-19

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical issued an update on its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $227 million-$230 million, compared to the consensus revenue estimate of $216.21 million.

What price target have analysts set for STAA?

5 equities research analysts have issued 12 month price objectives for STAAR Surgical's shares. Their forecasts range from $150.00 to $150.00. On average, they anticipate STAAR Surgical's stock price to reach $150.00 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price.
View analysts' price targets for STAAR Surgical
or view top-rated stocks among Wall Street analysts.

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Caren L. Mason, President, Chief Executive Officer & Director
  • Graydon Hansen, Chief Manufacturing Officer & SVP-Global Operation
  • Patrick F. Williams, Chief Financial Officer & Vice President (LinkedIn Profile)
  • Keith Holliday, Chief Technology Officer
  • Scott D. Barnes, Chief Medical Officer

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), The Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), The Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (11.53%), Assenagon Asset Management S.A. (0.10%), New York State Teachers Retirement System (0.10%), Genesee Capital Advisors LLC (0.05%), Covenant Asset Management LLC (0.03%) and Strs Ohio (0.03%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends for STAAR Surgical

Which institutional investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Strs Ohio, Hillsdale Investment Management Inc., Crossmark Global Holdings Inc., and Louisiana State Employees Retirement System. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical
or view top insider-selling stocks.

Which institutional investors are buying STAAR Surgical stock?

STAA stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Genesee Capital Advisors LLC, Covenant Asset Management LLC, New York State Teachers Retirement System, Dfpg Investments LLC, Wedbush Securities Inc., Pacer Advisors Inc., and Avantax Advisory Services Inc..
View insider buying and selling activity for STAAR Surgical
or or view top insider-buying stocks.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $124.62.

How much money does STAAR Surgical make?

STAAR Surgical has a market capitalization of $5.91 billion and generates $163.46 million in revenue each year. The medical instruments supplier earns $5.91 million in net income (profit) each year or $0.35 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 575 workers across the globe.

Does STAAR Surgical have any subsidiaries?

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

Where are STAAR Surgical's headquarters?

STAAR Surgical is headquartered at 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at (626) 303-7902 or via email at [email protected].

This page was last updated on 10/26/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.